PHS 398 Human N N Multi Y For Revision and W Answering to ‘Yes’ Cover Subjects NIH, 4.0 all Resubmission Clinical Trial on the Page Clinical CDC, and applications, If Overall component Trial FDA, Clinical Trial is and to Clinical ‘No’ (Y/N) AHRQ, No on all Trial on all other USU components of components is the application typically not allowed and the Overall Clinical Trial is unless your Revision Yes, provide application (or Warning Resubmission of a Revision) does not include the components that involve Clinical Trial. PHS 398 Human N N Incl: Provide a Clinical Trials are not W Forms D, Cover Subjects NIH, 4.0 S10 warning if Human typically allowed for March Page Clinical CDC, and Subjects Clinical this type of funding 2016 Trial FDA, Trial is mark opportunity Release (Y/N) AHRQ, announcement. ‘Yes’. USU PHS 398 Human N N : Both Both An answer is You must answer the E Forms D, Cover Subjects NIH, 4.0 required if the March “Agency-Defined Page CDC, and answer to Phase III Clinical 2016 Trial” Defined FDA, Subjects question if you answer Release ‘Human Phase III AHRQ, Clinical is Yes to the Trial’ “Clinical Clinical USU "Yes". question. Trial?” Trial (Y/N) PHS 398 Human N N Both Both If Human You cannot answer E Forms D, Cover Subjects NIH, 4.0 Subjects Clinical Yes to the March Page CDC, and Trial is No, this Phase III 2016 Defined FDA, cannot be equal Clinical Release Trial”question Phase III AHRQ, to Yes. if you anser No to the Clinical USU “Clinical Trial?” Trial question (Y/N)
PHS 398 Cover Page Human Subjects Clinical Trial (Y/N) N N NIH, CDC, FDA, AHRQ, USU 4.0 and Multi Y For Revision and Resubmission applications, If Clinical Trial is No on all components of the application and the Overall Clinical Trial is Yes, provide Warning Answering ‘Yes’ to Clinical Trial on the Overall component and ‘No’ to Clinical Trial on all other components is typically not allowed unless your Revision application (or Resubmission of a Revision) does not include the components that involve Clinical Trial. W PHS 398 Cover Page Human Subjects Clinical Trial (Y/N) N N NIH, CDC, FDA, AHRQ, USU 4.0 and Incl: S10 Provide a warning if Human Subjects Clinical Trial is mark ‘Yes’. Clinical Trials are not typically allowed for this type of funding opportunity announcement. W Forms D, March 2016 Release PHS 398 Cover Page Human Subjects Phase III Clinical Trial (Y/N) N N : NIH, CDC, FDA, AHRQ, USU 4.0 and Both Both An answer is required if the answer to ‘Human Subjects Clinical Trial’ is "Yes". You must answer the “Agency-Defined Phase III Clinical Trial” question if you answer Yes to the “Clinical Trial?” question. E Forms D, March 2016 Release PHS 398 Cover Page Human Subjects Phase III Clinical Trial (Y/N) N N NIH, CDC, FDA, AHRQ, USU 4.0 and Both Both If Human Subjects Clinical Trial is No, this cannot be equal to Yes. You cannot answer Yes to the Phase III Clinical Trial”question if you anser No to the “Clinical Trial?” question E Forms D, March 2016 Release Defined Defined all
eSub-validations-draft-07-12-2018.docx